ID: ALA5181165

Max Phase: Preclinical

Molecular Formula: C79H103N21O16

Molecular Weight: 1602.82

Representations

Canonical SMILES:  CCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O

Standard InChI:  InChI=1S/C79H103N21O16/c1-4-5-20-56(95-77(116)67(44(2)3)100-68(107)54(80)33-46-25-28-52(101)29-26-46)69(108)89-41-64(102)92-62(37-51-40-85-43-91-51)75(114)97-60(35-47-24-27-48-17-9-10-18-49(48)32-47)73(112)93-58(23-14-31-87-79(83)84)72(111)98-61(36-50-39-88-55-21-12-11-19-53(50)55)74(113)99-63(38-65(103)104)76(115)94-57(22-13-30-86-78(81)82)71(110)96-59(70(109)90-42-66(105)106)34-45-15-7-6-8-16-45/h6-12,15-19,21,24-29,32,39-40,43-44,54,56-63,67,88,101H,4-5,13-14,20,22-23,30-31,33-38,41-42,80H2,1-3H3,(H,85,91)(H,89,108)(H,90,109)(H,92,102)(H,93,112)(H,94,115)(H,95,116)(H,96,110)(H,97,114)(H,98,111)(H,99,113)(H,100,107)(H,103,104)(H,105,106)(H4,81,82,86)(H4,83,84,87)/t54-,56-,57-,58-,59-,60+,61+,62-,63-,67-/m0/s1

Standard InChI Key:  OKHXBJLIBJDJMV-RAEQEVBASA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 1602.82

Molecular Weight (Monoisotopic): 1601.7892

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Gimenez LE, Noblin TA, Williams SY, Mullick Bagchi S, Ji RL, Tao YX, Jeppesen CB, Conde-Frieboes KW, Sawyer TK, Grieco P, Cone RD..  (2022)  Demonstration of a Common DPhe⁷ to DNal(2')⁷ Peptide Ligand Antagonist Switch for Melanocortin-3 and Melanocortin-4 Receptors Identifies the Systematic Mischaracterization of the Pharmacological Properties of Melanocortin Peptides.,  65  (8.0): [PMID:35404053] [10.1021/acs.jmedchem.1c01295]

Source

Source(1):

• Scientific Literature